A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma

NCT06104553 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: SHR-A1912; R-Chemo
DRUG: SHR-A1912; R-Chemo

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.